Reactivation of Epstein-Barr virus from latency, Rev Med Virol, vol.15, pp.149-156, 2005. ,
Rheumatoid arthritis and cancer risk, Eur J Cancer Oxf Engl, vol.32, pp.1753-1757, 1990. ,
Epstein-Barr virus-related posttransplant lymphoproliferative disorder in solid organ transplant recipients, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.20, pp.109-118, 2014. ,
EBV viral load detection in clinical virology, J Clin Virol Off Publ Pan Am Soc Clin Virol, vol.48, pp.82-90, 2010. ,
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Crosssectional Survey, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.21, pp.604-605, 2015. ,
Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis, Arthritis Rheum, vol.57, pp.762-767, 2007. ,
CTLA4 blockade maximizes antitumor T-cell activation by dendritic cells presenting idiotype protein or opsonized anti-CD20 antibody-coated lymphoma cells, J Immunother Hagerstown Md, vol.25, pp.455-468, 1997. ,
The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritis, Expert Opin Investig Drugs, vol.12, pp.673-681, 2003. ,
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig, N Engl J Med, vol.349, pp.1907-1915, 2003. ,
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition, N Engl J Med, vol.353, pp.1114-1123, 2005. ,
Interleukin-6: a new therapeutic target, Arthritis Res Ther, vol.8, issue.2, p.5, 2006. ,
Interleukin-6 in rheumatoid arthritis, Curr Opin Rheumatol, vol.18, pp.277-281, 2006. ,
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate, Arthritis Rheum, vol.54, pp.2817-2829, 2006. ,
Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders. Drugs Today Barc Spain, vol.42, pp.559-576, 1998. ,
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial, Lancet Lond Engl, vol.371, pp.987-997, 2008. ,
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.5, pp.443-453, 2005. ,
Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant, Exp Clin Transplant Off J Middle East Soc Organ Transplant, vol.12, pp.212-219, 2014. ,
Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis, Jt Bone Spine Rev Rhum, vol.83, pp.412-415, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01883187
Monitoring of Epstein-Barr virus load and killer T cells in patients with juvenile idiopathic arthritis treated with methotrexate or tocilizumab, Mod Rheumatol Jpn Rheum Assoc, pp.1-6, 2016. ,
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, vol.31, pp.315-324, 1988. ,
Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity, Arthritis Rheum, vol.38, pp.38-43, 1995. ,
Longitudinal Data Analysis Using Generalized Linear Models, Biometrika, vol.73, pp.13-22, 1986. ,
, The R Project for Statistical Computing, 2016.
Estimating equations for association structures, Stat Med, vol.23, pp.859-874, 2004. ,
Rheumatoid arthritis and malignant lymphomas, Curr Opin Rheumatol, vol.16, pp.254-261, 2004. ,
Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis, Arthritis Rheum, vol.54, pp.3774-3781, 2006. ,
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis, Arthritis Rheum, vol.54, pp.692-701, 2006. ,
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis, Arthritis Res Ther, vol.10, p.45, 2008. ,
High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders, J Clin Microbiol, vol.38, pp.613-619, 2000. ,
Circulating Epstein-Barr virus DNA to monitor lymphoproliferative disease following pediatric liver transplantation, Transpl Int Off J Eur Soc Organ Transplant, vol.13, issue.1, pp.399-401, 2000. ,
Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France, Blood, vol.99, pp.3909-3915, 2002. ,
Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation, J Clin Virol Off Publ Pan Am Soc Clin Virol, vol.53, pp.186-194, 2012. ,
Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis, JAMA, vol.308, pp.898-908, 2012. ,
Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries, Rheumatol Oxf Engl, vol.50, pp.222-229, 2011. ,
Adverse effects of biologics: a network meta-analysis and Cochrane overview, Cochrane Database Syst Rev, vol.008794, 2011. ,
Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program, J Rheumatol, vol.40, pp.787-797, 2013. ,
Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registry, Rheumatol Oxf Engl, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01881520
Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis, Viral Immunol, vol.28, pp.385-390, 2015. ,
Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody, Ann Rheum Dis, vol.65, pp.1667-1669, 2006. ,
Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan, Mod Rheumatol Jpn Rheum Assoc, pp.1-9, 2016. ,